Ingredient and formulation
Liposomal caffeine
We consider active content, carrier structure and manufacturing conditions together for caffeine formulations. For a liposomal caffeine project, the technical dossier is assessed against the intended product format and documented ingredient properties.
What does liposomal caffeine mean?
Liposomal caffeine describes caffeine formulated with a phospholipid-based delivery system. The caffeine amount alone does not define the ingredient: phospholipid source, excipients and the carrier’s structural properties also form part of the technical assessment.
The word liposomal does not, by itself, establish slow release, a longer-lasting effect or fewer adverse effects. We build the project around the selected commercial grade’s measured and documented properties.
How much active is associated with the carrier?
Total caffeine and the amount incorporated into the carrier are different parameters. The HPLC assay, encapsulation efficiency and free caffeine data should be read together. A percentage comparison also needs its unit and calculation basis.
A laboratory investigation of caffeine and model lipid membranes shows that preparation conditions matter to this interaction. It does not assign a release duration to a commercial product; it illustrates why carrier measurements and their methods need to be documented.
Source: Tavagnacco et al., 2021
Release testing and human studies answer different questions.
A laboratory release test examines how the active is released in a defined medium under specified conditions. Assessing absorption rate, total exposure or duration of effect in people requires a study designed for that question. One result cannot replace the other.
Research on coated caffeine-loaded nanoliposomes evaluates structure, surface properties and thermal behaviour. This is a formulation study. Its results do not establish clinical superiority or equivalent effects at a lower dose for every liposomal caffeine ingredient.
Source: Mokhtari et al., 2025
Plan around your manufacturing conditions.
Capsule and sachet projects consider flow, blend uniformity and moisture. Liquid products require assessment of pH, taste, appearance and packaging compatibility. Processing temperature and mixing conditions also belong in the sample evaluation plan.
Where more than one ingredient contributes caffeine, the combined amount is calculated. The destination market’s product category and labelling requirements are reviewed alongside the proposed ingredients and use. We define the document, sample and sourcing scope within that framework.
What we assess in the technical dossier
| Parameter | Information to assess |
|---|---|
| Active content | Caffeine identity, total amount and appropriate analytical method |
| Delivery system | Phospholipid source, excipients, allergen and composition information |
| Encapsulation and structure | Free/carrier-associated active, measurement approach and structural data |
| Release and stability | Test conditions, available release profile and storage data |
| Project and sourcing | Product format, other caffeine sources, destination market and annual requirement |
Common questions
Is liposomal caffeine necessarily slow release?
No. The release profile depends on the selected formulation and test conditions. A slow-release statement requires appropriate supporting data for that product.
Is caffeine content the same as total ingredient weight?
No. An ingredient can contain a carrier and excipients alongside caffeine. Formulation calculations use the caffeine amount per gram or millilitre.
Does a liposomal structure allow a lower dose?
That claim requires appropriate research on the relevant formulation and comparator. The liposomal name or encapsulation percentage alone does not establish dose equivalence.
How does sample assessment begin?
Share the intended product format, planned caffeine amount, other ingredients, destination market and estimated annual requirement. We can assess a suitable commercial grade and define the sample scope from the available technical documentation.
Technical library
Better questions. Stronger formulations.
What is liposomal technology? From ingredient to formulation
A Biontera guide to liposomal ingredient structure, the role of phospholipids and the technical evidence used in product development.
Liposomal and water-soluble forms: what is the difference?
Understand the difference between liposomal structure, water solubility and bioavailability when comparing nutraceutical ingredient specifications.
How to read bioavailability studies
A practical guide to AUC, Cmax, active dose and comparators when assessing liposomal ingredient research for product development.
Start with the right ingredient.
Share your product format, destination market and annual requirement. Let’s assess suitable commercial grades, technical documents and the sample process together.